Antipodes Partners’s Natera NTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87.4K Buy
322
+42
+15% +$8.96K ﹤0.01% 106
2026
Q1
$56K Sell
280
-50
-15% -$10.8K ﹤0.01% 106
2025
Q4
$75.6K Hold
330
﹤0.01% 95
2025
Q3
$53.1K Buy
330
+17
+5% +$2.69K ﹤0.01% 94
2025
Q2
$52.9K Buy
313
+30
+11% +$4.67K ﹤0.01% 85
2025
Q1
$40K Buy
+283
New +$45.5K ﹤0.01% 83

Other funds holding NTRA

Antipodes Partners's NTRA Position: Q2 2026 in Review

Antipodes Partners increased its Natera (NTRA) stake by 15% in Q2 2026, buying an estimated $8.96K and bringing the position to 322 shares worth $87.4K. The position accounts for ﹤0.01% of the portfolio, ranked #106.

Antipodes Partners first reported a position in NTRA in Q1 2025 and has held it in 6 quarters since. 435 funds tracked by Wall St. Rank hold NTRA as of Q2 2026.

  • Antipodes Partners held 322 shares of Natera worth $87.4K as of Q2 2026.
  • Antipodes Partners bought 42 Natera shares in Q2 2026, an estimated $8.96K.
  • Natera made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #106 holding.
  • Antipodes Partners first reported a position in Natera in Q1 2025 and has held it in 6 quarters since.
  • 435 funds tracked by Wall St. Rank held Natera as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.